findmyKOL

John Reveille, MD

Basic profile

The University of Texas Health Science Center

ORCIDNPI
RegionHouston, TX · South CentralSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2018Online presenceNot yet checkedPayments2021 onwardNIH funding1988–2016

John Reveille is a Rheumatology/Immunology physician affiliated with The University of Texas Health Science Center. OpenAlex indexes 593 publications with 43,819 citations (h-index 107); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Rheumatology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
593publications

Distinct works indexed by OpenAlex, matched via ORCID.

43,819citations

Total citations across indexed works.

107h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
7NIH grants · 1988–2016

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6410 Fannin St
600
Houston, TX 770303000

Telephone

832-325-7191

Registry record last updated 11 Feb 2008.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    34.1%
    Corticosteroid34.1%
    Triamcinolone acetonide100%
    Part B, office-administered19 patients
  • Nervous system

    25%
    Gabapentinoids12.8%
    Gabapentin74%Pregabalin26%
    Part D<11 patients
    Nonsteroidal Anti-inflammatory Drug5.1%
    Meloxicam100%
    Part D<11 patients

    + 2 more classes in this area

  • Cancer & immunology

    25%
    Folate Analog Metabolic Inhibitor6.9%
    Methotrexate100%
    Part D<11 patients
    JAK inhibitor6.9%
    Rinvoq66%Xeljanz Xr34%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

7 NIH research awards on record, funded 19882016 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”